AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

PRO MEDICUS LTD

179.390

-2.090-1.15%

Volume:252.38K

Turnover:45.29M

Market Cap:18.75B

PE:70.74

High:181.340

Open:179.890

Low:176.715

Close:181.480

52wk High:320.685

52wk Low:107.453

Shares:104.51M

Float Shares:52.96M

Volume Ratio:1.01

T/O Rate:0.48%

Dividend:0.62

Dividend Rate:0.34%

EPS(TTM):2.536

EPS(LYR):2.536

ROE:74.97%

ROA:25.84%

PB:41.58

PE(LYR):70.74

Loading ...

Overview Company News Filings

Why buying ASX shares in March could supercharge your wealth

Morgans says these ASX 200 shares could rise 120%

Are these the smartest ASX tech stocks to buy now with $2,000?

3 ASX healthcare stocks tipped to soar over 100% higher this year

Why Brightstar, EQ Resources, Novonix, and Pro Medicus shares are falling today

Why New Hope, Pepper Money, Pro Medicus, and Reece shares are falling today

Australian shares: A once-in-a-decade chance to build wealth?

Should you buy CSL and Pro Medicus shares today?

BRIEF-Pro Medicus Says Danny English Will Become CFO

Pro Medicus Promotes Head of Finance to CFO

MT Newswires Live

Pro Medicus Ltd - CFO Clayton Hatch to Assume Newly Created Dual Roles of Head of Business Operations & Head of Investor Relations

THOMSON REUTERS

Pro Medicus Ltd - Danny English Will Become Chief Financial Officer

THOMSON REUTERS

Pro Medicus Ltd-Senior Management Appointments

THOMSON REUTERS

3 ASX growth shares that could benefit from the AI boom

3 ASX stocks brokers say could double in the next year

Should Pro Medicus’ (ASX:PME) New US Contracts and Cardiology Push Require Action From Investors?

Simply Wall St.

Assessing Pro Medicus’s Valuation After New US Contracts And Visage 7 Product Updates

Simply Wall St.

A leading investor just bought these ASX 200 shares for income and growth

Top 10 ASX 200 Stocks to Consider Following Market Downturn

BRIEF-Pro Medicus Signs Two 5-Year Contract Renewals Total Minimum A$40 Mln

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/PME.AU/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PME.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"PME.AU\",,,,,undefined,":{"symbol":"PME.AU","market":"AU","secType":"STK","nameCN":"PRO MEDICUS LTD","latestPrice":179.39,"timestamp":1788156720000,"preClose":181.48,"halted":0,"volume":252383,"delay":0,"changeRate":-0.011516420542208528,"nameEN":"PRO MEDICUS LTD","floatShares":52960584,"shares":104510839,"eps":2.535999,"marketStatus":"Closed","change":-2.09,"latestTime":"08-31 16:12:00 AEST","open":179.89,"high":181.34,"low":176.715,"amount":45292010,"amplitude":0.025485,"askPrice":181,"askSize":2,"bidPrice":179,"bidSize":9,"shortable":3,"etf":0,"ttmEps":2.535999,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1788220800000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":181.48,"dividendRate":0.003439,"openAndCloseTimeList":[[1788134400000,1788156000000]],"volumeRatio":1.011067,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"PME.AU","preClose":181.48,"auctionPrice":179.39,"auctionVolume":149190,"auctionTime":1788156606439,"referencePrice":179.39,"referenceTime":1788172203092,"auction":3,"marketStatus":"盘后竞价","timestamp":1788156606439}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"PME.AU\",,,,,undefined,":{"symbol":"PME.AU","floatShares":52960584,"roa":"25.84%","roe":"74.97%","lyrEps":2.535999,"volumeRatio":1.011067,"shares":104510839,"dividePrice":0.617,"high":181.34,"amplitude":0.025485,"preClose":181.48,"low":176.715,"week52Low":107.453,"pbRate":"41.58","psRate":"71.64","week52High":320.685,"institutionHeld":0,"latestPrice":179.39,"committee":0.636364,"eps":2.535999,"divideRate":0.003439,"volume":252383,"delay":0,"ttmEps":2.535999,"open":179.89,"prevYearClose":220.262,"prevWeekClose":181.48,"prevMonthClose":162.21,"prevQuarterClose":203.43,"fiveDayClose":193.43,"twentyDayClose":164.69,"sixtyDayClose":165.64,"dividendPayoutRate":0.24411995739713002,"dividendGrowthYears":7,"dividendGrowthRate":0.31914893617021284,"fiveYearAvgDividendRate":0.0030604857555623804},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PME.AU\",params:#limit:5,,,undefined,":[{"date":"2026-09-07","symbol":"PME.AU","amount":0.37,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-09-08","defaultRemindTime":1788739200000,"name":"PRO MEDICUS LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-29","payableDate":"2026-09-08","currency":"AUD","dateTimestamp":1788703200000,"payDate":"2026-09-29"},{"date":"2026-08-18","symbol":"PME.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787011200000,"name":null,"time":"","dateTimestamp":1786975200000,"actualEps":null},{"date":"2026-02-26","symbol":"PME.AU","amount":0.32,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-02-27","name":"PRO MEDICUS LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-20","payableDate":"2026-02-27","currency":"AUD","dateTimestamp":1772024400000,"payDate":"2026-03-20"},{"date":"2026-02-12","symbol":"PME.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1770850800000,"name":null,"time":"","dateTimestamp":1770814800000,"actualEps":null},{"date":"2025-09-03","symbol":"PME.AU","amount":0.3,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-09-04","defaultRemindTime":1756857600000,"name":"PRO MEDICUS LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-25","payableDate":"2025-09-04","currency":"AUD","dateTimestamp":1756821600000,"payDate":"2025-09-25"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PME.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-09-10","recordDate":"2020-09-11","paymentDate":"2020-10-02","value":0.06,"currency":"AUD"},{"executeDate":"2021-03-04","recordDate":"2021-03-05","paymentDate":"2021-03-19","value":0.07,"currency":"AUD"},{"executeDate":"2021-09-09","recordDate":"2021-09-10","paymentDate":"2021-10-01","value":0.08,"currency":"AUD"},{"executeDate":"2022-03-03","recordDate":"2022-03-04","paymentDate":"2022-03-25","value":0.1,"currency":"AUD"},{"executeDate":"2022-09-08","recordDate":"2022-09-09","paymentDate":"2022-09-30","value":0.12,"currency":"AUD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PME.AU\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2621754485","title":"Why buying ASX shares in March could supercharge your wealth","url":"https://stock-news.laohu8.com/highlight/detail?id=2621754485","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621754485?lang=en_us&edition=fundamental","pubTime":"2026-03-21 05:00","pubTimestamp":1774040400,"startTime":"0","endTime":"0","summary":"The prices we're seeing now and in the coming weeks could be some of the best value ASX shares available to investors this year, or even the rest of the decade. It's not often that share prices go through a decline of 10% or more. Widespread selling is painful as a shareholder but there are lower valuations  across the board for brave prospective investors. Sell-offs give us the chance to search across the S&P/ASX 300 Index   to find beaten-up opportunities which could then bounce back when market confidence returns. Assuming the investment still has a positive long-term outlook, a large decline is a great opportunity to see big returns if/when there's a recovery. For example, if a share price drops by 50%, then returning to the previous position would be a return of 100%!","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/21/why-buying-asx-shares-in-march-could-supercharge-your-wealth/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/21/why-buying-asx-shares-in-march-could-supercharge-your-wealth/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["PME.AU","REA.AU","BK7016","UNI.AU","BK7503","SDR.AU","NCK.AU","BK7094","TNE.AU","BK7119","BK7107","PNI.AU","BK7002","BK7049","GYG.AU","AEF.AU","TUA.AU","BK7103","BK7137","XRO.AU","LOV.AU","SIG.AU","BK7128","BRG.AU","BK7021","L1G.AU","TPW.AU","BK7042","XKO.AU","BK7062"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620270276","title":"Morgans says these ASX 200 shares could rise 120%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620270276","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620270276?lang=en_us&edition=fundamental","pubTime":"2026-03-20 08:21","pubTimestamp":1773966106,"startTime":"0","endTime":"0","summary":"There could be some dirt cheap ASX 200 shares out there according to analysts at Morgans. For example, the two shares in this article could more than double in value from current levels according to t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/20/morgans-says-these-asx-200-shares-could-rise-120/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/20/morgans-says-these-asx-200-shares-could-rise-120/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["NAV","BK7166","BK7094","DGT.AU","PME.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620505293","title":"Are these the smartest ASX tech stocks to buy now with $2,000?","url":"https://stock-news.laohu8.com/highlight/detail?id=2620505293","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620505293?lang=en_us&edition=fundamental","pubTime":"2026-03-19 06:13","pubTimestamp":1773872019,"startTime":"0","endTime":"0","summary":"It hasn't been a great year for many ASX tech stocks. Some of the market's highest-quality names have been sold off heavily, with investors worried about valuations, interest rates, and the impact of ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/19/are-these-the-smartest-asx-tech-stocks-to-buy-now-with-2000/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/19/are-these-the-smartest-asx-tech-stocks-to-buy-now-with-2000/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7094","XRO.AU","XLK","BK4588","TNE.AU","BK4585","PME.AU","BK7016","BK7503"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620818702","title":"3 ASX healthcare stocks tipped to soar over 100% higher this year","url":"https://stock-news.laohu8.com/highlight/detail?id=2620818702","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620818702?lang=en_us&edition=fundamental","pubTime":"2026-03-18 12:59","pubTimestamp":1773809940,"startTime":"0","endTime":"0","summary":"ASX healthcare stocks are a popular option for investors seeking defensive assets with long-term structural growth.These shares can offer portfolio diversification, drive high margins, and some of them have huge potential upside.Here are three ASX healthcare stocks on my radar this week, and analysts are tipping upside well over 100% over the next 12 months.The beaten-down medical imaging technology stock has dropped another 1.7% in Wednesday afternoon trade, to $125.69 a piece. The decline is part of a long string of declines off the back of sector-wide headwinds, which have seen the share price crash 62% from an all-time high recorded in mid-2025.Sentiment didn't improve when the company posted a record-breaking half-year FY26 result in mid-February. Its revenue was up 28%, and profit jumped nearly 30%, but it still missed investors' high expectations.Analysts are excited about the prospects for growth of the ASX healthcare stock's business fundamentals and share price over the next ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/18/3-asx-healthcare-stocks-tipped-to-soar-over-100-higher-this-year/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/18/3-asx-healthcare-stocks-tipped-to-soar-over-100-higher-this-year/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7067","CU6.AU","TLX.AU","BK7096","BK7094","PME.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620249283","title":"Why Brightstar, EQ Resources, Novonix, and Pro Medicus shares are falling today","url":"https://stock-news.laohu8.com/highlight/detail?id=2620249283","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620249283?lang=en_us&edition=fundamental","pubTime":"2026-03-18 11:02","pubTimestamp":1773802933,"startTime":"0","endTime":"0","summary":"In afternoon trade, theS&P/ASX 200 Index(ASX: XJO) is on course to record a modest gain. At the time of writing, the benchmark index is up 0.2% to 8,631.7 points. Four ASX shares that have failed to f","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/18/why-brightstar-eq-resources-novonix-and-pro-medicus-shares-are-falling-today/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/18/why-brightstar-eq-resources-novonix-and-pro-medicus-shares-are-falling-today/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["EQ","XJO.AU","BK7094","PME.AU","BK7506","NVX.AU","BK4568","BTR.AU","BK7095","BK7104","EQR.AU","BK7084","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620414344","title":"Why New Hope, Pepper Money, Pro Medicus, and Reece shares are falling today","url":"https://stock-news.laohu8.com/highlight/detail?id=2620414344","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620414344?lang=en_us&edition=fundamental","pubTime":"2026-03-17 10:46","pubTimestamp":1773715579,"startTime":"0","endTime":"0","summary":"TheS&P/ASX 200 Index(ASX: XJO) is having a subdued session on Tuesday and is trading marginally higher ahead of the RBA meeting. At the time of writing, the benchmark index is up a fraction to 8,588.9","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/17/why-new-hope-pepper-money-pro-medicus-and-reece-shares-are-falling-today/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/17/why-new-hope-pepper-money-pro-medicus-and-reece-shares-are-falling-today/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7160","BK4588","BK4585","BK7083","XJO.AU","NHC.AU","BK7123","CGF.AU","BK7112","VIG","BK7094","REH.AU","PME.AU","BK7031","PPM.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620497799","title":"Australian shares: A once-in-a-decade chance to build wealth?","url":"https://stock-news.laohu8.com/highlight/detail?id=2620497799","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620497799?lang=en_us&edition=fundamental","pubTime":"2026-03-17 06:30","pubTimestamp":1773700200,"startTime":"0","endTime":"0","summary":"At first glance, the Australian share market doesn't look particularly cheap.  Even after the recent pullback driven by escalating tensions in the Middle East, the S&P/ASX 200 Index (ASX: XJO) is stil","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/17/australian-shares-a-once-in-a-decade-chance-to-build-wealth/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/17/australian-shares-a-once-in-a-decade-chance-to-build-wealth/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7078","BK7103","BK7007","FLT.AU","BK7049","BK7097","ALL.AU","JHX.AU","BK7067","TLX.AU","AMC.AU","PME.AU","XJO.AU","BK7016","XAO.AU","BK7503","TWE.AU","CSL.AU","XKO.AU","SIG.AU","WTC.AU","BK7070","BK7094","XRO.AU","BK7511","BK7107","BK7501","COH.AU","BK7044","BK7508","BK7063","TPW.AU","BK7505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620951954","title":"Should you buy CSL and Pro Medicus shares today?","url":"https://stock-news.laohu8.com/highlight/detail?id=2620951954","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620951954?lang=en_us&edition=fundamental","pubTime":"2026-03-17 03:00","pubTimestamp":1773687600,"startTime":"0","endTime":"0","summary":"Healthcare shares have been among the biggest fallers on the ASX over the past year. Two of the sector's biggest names — CSL Ltd  and Pro Medicus Ltd  — have both seen their share prices slump heavily. They declined roughly 40% or more over the past 12 months. When CSL and Pro Medicus shares fall this far, investors often start asking the same question: is this a buying opportunity, or a sign that more downside is ahead?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/17/should-you-buy-csl-and-pro-medicus-shares-today/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/17/should-you-buy-csl-and-pro-medicus-shares-today/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["CSL","BK7508","BK7067","BK7511","BK7094","CSL.AU","LU0728928796.USD","SG9999004303.SGD","BK7501","LU1169589451.USD","SGXZ23171101.USD","LU1169590202.USD","PME.AU","BK4086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619487617","title":"BRIEF-Pro Medicus Says Danny English Will Become CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2619487617","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619487617?lang=en_us&edition=fundamental","pubTime":"2026-03-16 09:46","pubTimestamp":1773625561,"startTime":"0","endTime":"0","summary":"BRIEF-Pro Medicus Says Danny English Will Become CFOMarch 16  - Pro Medicus Ltd PME.AX:SENIOR MANAGEMENT APPOINTMENTSDANNY ENGLISH WILL BECOME CHIEF FINANCIAL OFFICERCFO CLAYTON HATCH TO ASSUME NEWLY CREATED DUAL ROLES OF HEAD OF BUSINESS OPERATIONS & HEAD OF INVESTOR RELATIONSFurther company coverage: PME.AX ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nTUE3T9BMX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PME.AU","BK7094"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619892794","title":"Pro Medicus Promotes Head of Finance to CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2619892794","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619892794?lang=en_us&edition=fundamental","pubTime":"2026-03-16 07:43","pubTimestamp":1773618180,"startTime":"0","endTime":"0","summary":"Pro Medicus  appointed Danny English, head of finance and company secretary, as chief financial officer, effective Monday, according to a same-day Australian bourse filing.English will succeed Clayton Hatch, who will assume the newly created dual roles of head of business operations and head of investor relations, the filing added.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7094","PME.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619748619","title":"Pro Medicus Ltd -  CFO Clayton Hatch to Assume Newly Created Dual Roles of Head of Business Operations & Head of Investor Relations","url":"https://stock-news.laohu8.com/highlight/detail?id=2619748619","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619748619?lang=en_us&edition=fundamental","pubTime":"2026-03-16 06:40","pubTimestamp":1773614433,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260315:nTUE3T9BMX:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PME.AU","BK7094"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619486162","title":"Pro Medicus Ltd - Danny English Will Become Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2619486162","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619486162?lang=en_us&edition=fundamental","pubTime":"2026-03-16 06:40","pubTimestamp":1773614433,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260315:nTUE3T9BMX:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PME.AU","BK7094"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619167486","title":"Pro Medicus Ltd-Senior Management Appointments","url":"https://stock-news.laohu8.com/highlight/detail?id=2619167486","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619167486?lang=en_us&edition=fundamental","pubTime":"2026-03-16 06:40","pubTimestamp":1773614433,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260315:nTUE3T9BMX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7094","PME.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619483465","title":"3 ASX growth shares that could benefit from the AI boom","url":"https://stock-news.laohu8.com/highlight/detail?id=2619483465","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619483465?lang=en_us&edition=fundamental","pubTime":"2026-03-16 04:33","pubTimestamp":1773606780,"startTime":"0","endTime":"0","summary":"Artificial intelligence (AI) is rapidly transforming industries across the global economy. From cloud computing and healthcare to data infrastructure and enterprise software, businesses are increasing","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/16/3-asx-growth-shares-that-could-benefit-from-the-ai-boom/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/16/3-asx-growth-shares-that-could-benefit-from-the-ai-boom/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK4528","BK7503","BK7016","BK4543","BK4023","BK7094","XRO.AU","PME.AU","AI","VGT","BK4588","BK4551","BK4585","NXT.AU","BK4587","AIYY","BK7043"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619483450","title":"3 ASX stocks brokers say could double in the next year","url":"https://stock-news.laohu8.com/highlight/detail?id=2619483450","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619483450?lang=en_us&edition=fundamental","pubTime":"2026-03-16 04:30","pubTimestamp":1773606600,"startTime":"0","endTime":"0","summary":"With March bringing significant volatility for ASX stocks, there is plenty of opportunity for value investors. Unsurprisingly, much of the opportunity lies with ASX healthcare and technology stocks th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/16/3-asx-stocks-brokers-say-could-double-in-the-next-year/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/16/3-asx-stocks-brokers-say-could-double-in-the-next-year/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7508","BK7016","BK7067","XJO.AU","BK7503","BK7501","BK7094","CSL.AU","BK7511","WTC.AU","PME.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619171722","title":"Should Pro Medicus’ (ASX:PME) New US Contracts and Cardiology Push Require Action From Investors?","url":"https://stock-news.laohu8.com/highlight/detail?id=2619171722","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619171722?lang=en_us&edition=fundamental","pubTime":"2026-03-15 07:23","pubTimestamp":1773530591,"startTime":"0","endTime":"0","summary":"In recent days, Visage Imaging, a wholly owned subsidiary of Pro Medicus, showcased new innovations for its Visage 7 Enterprise Imaging Platform and released Visage 7.1.20, while Pro Medicus also announced approximately A$40,000,000 in US contract renewals, including expanded work with MedStar Health and higher-fee renewals with Zwanger-Pesiri.\nBeyond reinforcing existing relationships, the MedStar renewal extends Pro Medicus further into cardiology imaging, signalling broader use of its...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-pme/pro-medicus-shares/news/should-pro-medicus-asxpme-new-us-contracts-and-cardiology-pu","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-pme/pro-medicus-shares/news/should-pro-medicus-asxpme-new-us-contracts-and-cardiology-pu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4211","BK4212","BK7094","PME.AU","ISBC","PME"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619452721","title":"Assessing Pro Medicus’s Valuation After New US Contracts And Visage 7 Product Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2619452721","media":"Simply Wall St.","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619452721?lang=en_us&edition=fundamental","pubTime":"2026-03-14 04:31","pubTimestamp":1773433888,"startTime":"0","endTime":"0","summary":"Pro Medicus (ASX:PME) is back in focus after securing about A$40 million in US contract renewals, including an expanded MedStar Health deal covering cardiology imaging and a higher fee renewal with Zwanger-Pesiri.\nSee our latest analysis for Pro Medicus.\nThese contract wins and product updates come after a tough share price stretch, with a 30 day share price return of 21.52% decline and a year to date share price return of 40.26% decline. However, the 3 year total shareholder return is...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-pme/pro-medicus-shares/news/assessing-pro-medicuss-valuation-after-new-us-contracts-and","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-pme/pro-medicus-shares/news/assessing-pro-medicuss-valuation-after-new-us-contracts-and","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PME.AU","BK7094"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619178141","title":"A leading investor just bought these ASX 200 shares for income and growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2619178141","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619178141?lang=en_us&edition=fundamental","pubTime":"2026-03-14 03:00","pubTimestamp":1773428400,"startTime":"0","endTime":"0","summary":"The investment team in charge of Australian Foundation Investment Co Ltd (ASX: AFI) (AFIC) has extensive experience selecting S&P/ASX 200 Index (ASX: XJO) shares to generate income and growth returns.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/14/a-leading-investor-just-bought-these-asx-200-shares-for-income-and-growth/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/14/a-leading-investor-just-bought-these-asx-200-shares-for-income-and-growth/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["JBH.AU","CAR.AU","BK7094","BK7135","BK7157","SEK.AU","AFI.AU","REA.AU","BK7042","BK7016","BK7062","ALQ.AU","TLX.AU","BK7124","NWL.AU","TLS.AU","BK7503","CBA.AU","XJO.AU","BK7040","CPU.AU","WBC.AU","BK7050","COL.AU","BK7001","BK7511","BK7033","BK7501","SHL.AU","BK7067","PME.AU","TNE.AU","NAB.AU","BK7082","BK7002"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157525084","title":"Top 10 ASX 200 Stocks to Consider Following Market Downturn","url":"https://stock-news.laohu8.com/highlight/detail?id=1157525084","media":"Trading Random","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157525084?lang=en_us&edition=fundamental","pubTime":"2026-03-10 10:14","pubTimestamp":1773108866,"startTime":"0","endTime":"0","summary":"The ASX 200 index experienced a significant decline on Monday, driven by a sharp increase in oil prices amid escalating tensions in the Middle East.While such market corrections can be concerning in...","market":null,"thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Top 10 ASX 200 Stocks to Consider Following Market Downturn","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0170899867.USD","BK4504","BK4567","BK4082","LNW.AU","BK7067","BK7016","COH.AU","BK7510","RMD.AU","BK7511","LU2008162690.USD","BK4588","BK7094","BK7155","BK7503","CSL.AU","IE00B5TLWC47.USD","XRO.AU","BK7501","BK4585","REA.AU","PME.AU","BK7007","BK4548","BK4167","TNE.AU","BK4077","BK7078","BK7002","LU2177674079.SGD","WTC.AU","GMG.AU","BK7508","BK7099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618480690","title":"BRIEF-Pro Medicus Signs Two 5-Year Contract Renewals Total Minimum A$40 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2618480690","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618480690?lang=en_us&edition=fundamental","pubTime":"2026-03-09 09:22","pubTimestamp":1773019340,"startTime":"0","endTime":"0","summary":"BRIEF-Pro Medicus Signs Two 5-Year Contract Renewals Total Minimum A$40 Mln March 9 (Reuters) - Pro Medicus Ltd PME.AX:PME SIGNS TWO 5-YEAR CONTRACT RENEWALS TOTAL MINIMUM A$40MFurther company coverage: PME.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nFWN3ZU1HO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PME.AU","BK7094"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":7,"totalSize":145,"code":"91000000","status":"200"}]}}